These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 20643940)
1. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Doores KJ; Bonomelli C; Harvey DJ; Vasiljevic S; Dwek RA; Burton DR; Crispin M; Scanlan CN Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13800-5. PubMed ID: 20643940 [TBL] [Abstract][Full Text] [Related]
2. The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. Bonomelli C; Doores KJ; Dunlop DC; Thaney V; Dwek RA; Burton DR; Crispin M; Scanlan CN PLoS One; 2011; 6(8):e23521. PubMed ID: 21858152 [TBL] [Abstract][Full Text] [Related]
3. Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains. Luallen RJ; Agrawal-Gamse C; Fu H; Smith DF; Doms RW; Geng Y Glycobiology; 2010 Mar; 20(3):280-6. PubMed ID: 19920089 [TBL] [Abstract][Full Text] [Related]
4. A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120. Astronomo RD; Lee HK; Scanlan CN; Pantophlet R; Huang CY; Wilson IA; Blixt O; Dwek RA; Wong CH; Burton DR J Virol; 2008 Jul; 82(13):6359-68. PubMed ID: 18434393 [TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140. Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173 [TBL] [Abstract][Full Text] [Related]
8. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies. Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410 [TBL] [Abstract][Full Text] [Related]
9. Antigenic properties of the HIV envelope on virions in solution. Ray K; Mengistu M; Yu L; Lewis GK; Lakowicz JR; DeVico AL J Virol; 2014 Feb; 88(3):1795-808. PubMed ID: 24284318 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual. Coss KP; Vasiljevic S; Pritchard LK; Krumm SA; Glaze M; Madzorera S; Moore PL; Crispin M; Doores KJ J Virol; 2016 Dec; 90(24):11132-11144. PubMed ID: 27707925 [TBL] [Abstract][Full Text] [Related]
11. Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. Dunlop DC; Bonomelli C; Mansab F; Vasiljevic S; Doores KJ; Wormald MR; Palma AS; Feizi T; Harvey DJ; Dwek RA; Crispin M; Scanlan CN Glycobiology; 2010 Jul; 20(7):812-23. PubMed ID: 20181792 [TBL] [Abstract][Full Text] [Related]
12. Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3. Cole KS; Steckbeck JD; Rowles JL; Desrosiers RC; Montelaro RC J Virol; 2004 Feb; 78(3):1525-39. PubMed ID: 14722307 [TBL] [Abstract][Full Text] [Related]
13. GP120: target for neutralizing HIV-1 antibodies. Pantophlet R; Burton DR Annu Rev Immunol; 2006; 24():739-69. PubMed ID: 16551265 [TBL] [Abstract][Full Text] [Related]
14. Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation. Termini JM; Church ES; Silver ZA; Haslam SM; Dell A; Desrosiers RC J Virol; 2017 Oct; 91(19):. PubMed ID: 28747495 [TBL] [Abstract][Full Text] [Related]
15. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529 [TBL] [Abstract][Full Text] [Related]
17. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN. Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785 [TBL] [Abstract][Full Text] [Related]
18. Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein. Behrens AJ; Vasiljevic S; Pritchard LK; Harvey DJ; Andev RS; Krumm SA; Struwe WB; Cupo A; Kumar A; Zitzmann N; Seabright GE; Kramer HB; Spencer DI; Royle L; Lee JH; Klasse PJ; Burton DR; Wilson IA; Ward AB; Sanders RW; Moore JP; Doores KJ; Crispin M Cell Rep; 2016 Mar; 14(11):2695-706. PubMed ID: 26972002 [TBL] [Abstract][Full Text] [Related]
19. Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding. Finzi A; Pacheco B; Xiang SH; Pancera M; Herschhorn A; Wang L; Zeng X; Desormeaux A; Kwong PD; Sodroski J J Virol; 2012 Sep; 86(17):8974-86. PubMed ID: 22696649 [TBL] [Abstract][Full Text] [Related]
20. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity. Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]